<?xml version="1.0" encoding="UTF-8"?>
<p>ADS enabled expansion
 <xref rid="cmdc202000524-bib-0012" ref-type="ref">12</xref> of a series
 <xref rid="cmdc202000524-bib-0013" ref-type="ref">13</xref> of antibacterial quinazolinones. Pd‐catalysed cascade chemistry was chosen to drive ADS due to its potential to yield products based on many possible scaffolds (including quinazolinones; Figure 
 <xref rid="cmdc202000524-fig-0004" ref-type="fig">4</xref>a). Here, the alternative products stem from the possibility of cross‐coupling with or without carbonylation, and with or without subsequent cyclisation. 
</p>
